Abbott Laboratories Stock Drops 4% Over Decline In Q1 Earnings
(RTTNews) - Shares of Abbott Laboratories (ABT) are falling about 4 percent on Thursday morning trading after the company announced a decline in first-quarter earnings to $1.07 billion, or $0.61 per share, from last year's $1.32 billion, or $0.76 per share.
The company's stock is currently trading at $97.21, down 4.21 percent or $4.27, over the previous close of $101.56 on the New York Stock Exchange. It has traded between $96.82 and $139.06 in the past one year.
However, the company's revenue for the period rose to $11.16 billion from $10.35 billion in the previous year. Additionally, the company stated that it now projects full-year 2026 adjusted EPS of $5.38 to $5.58.
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.